RS

Ruchita Sinha

Life Science and Healthcare VC | Operator | Scientist

San Francisco Bay Area

Invests in

Stages:

  • Min Investment:

    $500,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $2,000,000.00

Work Experience

  • General Partner

    2019

    Build and lead life science and healthcare investment practice. Invest in seed and Series A companies at the intersection of life science and tech. Investor and/or board member in: ⬩Axuall ⬩Brave Care ⬩Clever Care ⬩CuraFi ⬩Flourish Health ⬩Phenomic AI ⬩Shennon Bio ⬩SimBioSys ⬩Think Bioscience ⬩Yuvo Health

  • Advisor

    2019 - 2020

    Mahana Therapeutics joins technology and healthcare expertise to produce innovative and cutting-edge digital therapeutics products https://www.mahanatherapeutics.com/

2016 - 2019

  • Sr. Director of Investments

    2016 - 2019

    Help manage venture fund focused on investing in biotech, healthcare technology & services. Lead and manage biotech and digital health investments for corporate fund. As head of healthtech and science platforms, build out investment practice for the fund. Investors and/or board member in: ⬩Inozyme Pharma (INZY) ⬩Evidation Health ⬩Omada Health ⬩Click Therapeutics ⬩Curisium ⬩Aetion

2013 - 2016

  • Director, GE Ventures

    2013 - 2016

    Led and supported a range of initiatives with startups and GE including equity investments, partnerships, and portfolio management. Investor and/or board member in: ⬩Caremerge ⬩WinguMD ⬩Jiseki Health ⬩HeadSense

  • Director, Strategy, Portfolio Management, and Commercial Operations

    2010 - 2013

    Business development, strategic planning and portfolio management for multiple therapeutic areas including cardiovascular, diabetes, and oncology. - Lead and participate in both inorganic and organic drug development initiatives for specific business units, as well as, enterprise-level corporate strategy projects.

2007 - 2010

  • Sr. Consultant

    2007 - 2010

    Responsible for managing teams and working with senior management (VP/C-level) to deliver significant impact in strategy, business development, and sales & marketing for pharmaceutical, biotech, medical device, and medical diagnostic clients. Developed enterprise-level and business unit-level strategy, new product plans, and go-to-market strategies.

2001 - 2005

  • Research Associate

    2001 - 2005

    Member of molecular biology team responsible for identifying novel drug targets for internal and external research projects using Maxygen’s proprietary molecular breeding technology.